![Nicholas Lydon](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Nicholas Lydon
Founder at
Granite Biopharma LLC
Profile
Nicholas B. Lydon was the founder of Kinetix Pharmaceuticals, Inc., founded in 1997, where the title held was President & Chief Executive Officer.
Dr. Lydon was the founder of AnaptysBio, Inc., founded in 2005, where the title held was Director.
Dr. Lydon is the founder of Granite Biopharma LLC, founded in 2003, where the title held is Member.
Dr. Lydon was the founder of Blueprint Medicines Corp., founded in 2008, where the title held was Independent Director.
Dr. Lydon is the founder of Recludix Pharma, Inc., founded in 2019, where the title held is Director.
Dr. Lydon is also the founder of IDRx, Inc...
Dr. Lydon is currently Managing Member at Staurus Pharma LLC since 2011.
Former positions include Director at Ambit Biosciences Corp.
from 2004 to 2009, Vice President-Small Molecule Drug Discovery at Amgen, Inc. from 2000 to 2002, Principal at Schering-Plough Corp., and Principal at Ciba-Geigy AG from 1985 to 1996.
Education includes undergraduate studies at the University of Leeds and a doctorate from the University Of Dundee.
Nicholas Lydon active positions
| Companies | Position | Start |
|---|---|---|
Granite Biopharma LLC
 Granite Biopharma LLC Miscellaneous Commercial ServicesCommercial Services Provides consulting services | Founder | 01/01/2003 |
Staurus Pharma LLC | Corporate Officer/Principal | 01/01/2011 |
Recludix Pharma, Inc.
 Recludix Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company which develops novel small molecule medicines for inflammatory and immune related diseases | Founder | 01/01/2019 |
Former positions of Nicholas Lydon
| Companies | Position | End |
|---|---|---|
| BLUEPRINT MEDICINES CORPORATION | Founder | 18/06/2025 |
| AMBIT BIOSCIENCES CORP | Director/Board Member | 01/01/2009 |
| AMGEN INC. | Corporate Officer/Principal | 02/01/2002 |
Kinetix Pharmaceuticals, Inc.
 Kinetix Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Discovers small molecule drugs in the field of protein kinase inhibition | Chief Executive Officer | 01/12/2000 |
Ciba-Geigy AG
 Ciba-Geigy AG Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Corporate Officer/Principal | 31/12/1996 |
Training of Nicholas Lydon
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
65
1st degree connections
13
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 13 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical & health care products | Health Technology |
Ambit Biosciences Corp.
 Ambit Biosciences Corp. Pharmaceuticals: MajorHealth Technology Develops and sells molecule kinase inhibitors for the treatment of cancer | Health Technology |
AnaptysBio, Inc.
 AnaptysBio, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company | Health Technology |
Ciba-Geigy AG
Ciba-Geigy AG Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Health Technology |
Kinetix Pharmaceuticals, Inc.
Kinetix Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Discovers small molecule drugs in the field of protein kinase inhibition | Commercial Services |
University of Leeds
 University of Leeds Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University Of Dundee
 University Of Dundee Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Blueprint Medicines Corp.
 Blueprint Medicines Corp. BiotechnologyHealth Technology Develops cancer therapies that harness the growing understanding of the molecular blueprint of cancer | Health Technology |
Granite Biopharma LLC
Granite Biopharma LLC Miscellaneous Commercial ServicesCommercial Services Provides consulting services | Commercial Services |
Staurus Pharma LLC | |
Recludix Pharma, Inc.
Recludix Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company which develops novel small molecule medicines for inflammatory and immune related diseases | Commercial Services |
IDRx, Inc.
 IDRx, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company dedicated to transforming cancer treatment | Health Technology |
- Stock Market
- Insiders
- Nicholas Lydon
